The Sanford Guide to Antimicrobial Therapy 2019

4.375 x 6.5 inches (Pocket Edition, approximate 5.5pt font).

The 49th edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug
information.
Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, the Sanford
Guide
provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician
assistants,
nurse practitioners, and others, the Sanford Guide to Antimicrobial Therapy provides information that is convenient,
concise,
and reliable.



New in 2019:

Table 1: osteomyelitis, mastitis, brain abscess, encephalitis, meningitis, otitis media, keratitis, gastroenteritis,
urethritis, syphilis, pyelonephritis, vaginosis, endocarditis, prosthetic joint, UTIs, pneumonia (esp. GNB),
pancreatitis,
peritonitis, bites, burns, cellulitis, Lyme, febrile syndromes, sepsis, shock, botulism, IV lines/catheters, vascular

Table 2: resistant bacteria, including GNB

Table 3: duration of therapy

Table 4: organism coverage expanded, drugs added (new and old)

Table 5B: updated treatment options for GNB

Table 6: updated recommendations for management of MRSA

Table 8: pregnancy risk for new drugs Table 9: PK & interactions data for new drugs added

Table 10: dosing updated and recent drugs added, e.g., plazomicin, eravacycline, omadacycline, temocillin, secnidazole

Table 11: cryptococcosis

Table 12: latent TB, MAC, M. abscessus

Table 13: malaria, tafenoquine

Table 14A: hemorrhagic fevers, influenza

Table 14B: new HCV, CMV drugs

Table 14C: new ARV drugs & combinations, updated recommended ART regimens

Table 14F: updated HCV treatment regimens and recommendations

Table 15: post-exposure prophylaxis

Table 16: added peds dosing for additional antibacterials, ARVs, antivirals

Table 17: renal adjustments for new drugs added

Table 17C: updated obesity dose adjustments

Table 22: DDIs reworked to focus on effects and suggested management